Cutler Group LP Heron Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 14, 2022	BUY	$4.63 - $9.94 $7,408 - $15,904	1,600 Added 800.0%	1,800 $15,000
Q4 2020 Jan 21, 2021	SELL	$14.61 - $22.14 $185,547 - $281,178	-12,700 Reduced 98.45%	200 $0
Q3 2020 Oct 27, 2020	BUY	$13.67 - $17.77 $28,707 - $37,317	2,100 Added 19.44%	12,900 $16,000
Q2 2020 Jul 22, 2020	SELL	$10.89 - $21.47 $154,638 - $304,874	-14,200 Reduced 56.8%	10,800 $31,000
Q1 2020 May 07, 2020	BUY	$10.23 - $24.56 $255,750 - $614,000	25,000 New	25,000 $41,000
Q4 2019 Feb 06, 2020	SELL	$17.42 - $26.61 $60,970 - $93,135	-3,500 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$16.36 - $21.39 $106,340 - $139,035	-6,500 Reduced 65.0%	3,500 $3,000
Q2 2019 Aug 09, 2019	BUY	$16.93 - $26.22 $155,756 - $241,224	9,200 Added 1150.0%	10,000 $4,000
Q1 2019 May 10, 2019	SELL	$23.15 - $28.34 $67,135 - $82,186	-2,900 Reduced 78.38%	800 $0
Q2 2018 Aug 10, 2018	SELL	$26.4 - $42.0 $343,200 - $546,000	-13,000 Reduced 77.84%	3,700 $2,000
Q1 2018 May 11, 2018	BUY	$18.43 - $28.8 $232,218 - $362,880	12,600 Added 307.32%	16,700 $7,000
Q4 2017 Jan 17, 2018	BUY	$14.8 - $18.85 $38,480 - $49,010	2,600 Added 173.33%	4,100 $0
Q3 2017 Oct 17, 2017	BUY	$14.65 - $16.85 $21,975 - $25,275	1,500	1,500 $0

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $188M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.